Anaplastic Astrocytoma Drug Market Report

Global and Region Anaplastic Astrocytoma Drug Market Demand & Opportunity Outlook 2022-2028

  • POSTDATE：Jul 31, 2022
  • PAGES：182
  • REPORT CODE：GMM936456
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • The report details the trend, potential and market size of Anaplastic Astrocytoma Drug market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.

    The first part (Chapter1-7) mainly covers the qualitative analysis of Anaplastic Astrocytoma Drugmarket, defines the market attractiveness level of Anaplastic Astrocytoma Drug market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.

    The second part (Chapter8-12), based on the segmentation of Anaplastic Astrocytoma Drug industry, describes the types of Anaplastic Astrocytoma Drug market, the applications of major players and the market size, and deeply analyzes the current situation of the global Anaplastic Astrocytoma Drug market and the development prospects and opportunities of Anaplastic Astrocytoma Drug industry.

    The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.

    As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Anaplastic Astrocytoma Drug market in Chapter 13.

    By Player:

    • TVAX Biomedical Inc

    • Advantagene Inc

    • Alfa Wassermann SpA

    • ZIOPHARM Oncology Inc

    • Burzynski Research Institute Inc

    • Orbus Therapeutics Inc

    • AngioChem Inc

    • Bayer AG

    • Boehringer Ingelheim GmbH

    • Merrimack Pharmaceuticals Inc

    • Novartis AG

    • Millennium Pharmaceuticals Inc

    • Cavion LLC

    • Astellas Pharma Inc

    • Tragara Pharmaceuticals Inc

    • Amgen Inc

    • Pfizer Inc

    • Celldex Therapeutics Inc

    • Tocagen Inc

    By Type:

    • A-10

    • AS-21

    • AdRTSIL-12

    • ADU-623

    • Others

    By End-User:

    • Hospital

    • Clinic

    • Others

    By Geography:

    • United States

    • Europe

    • China

    • Japan

    • India

    • South Korea

  • TABLE OF CONTENT

    1 Introduction

    • 1.1 Market Definition

    • 1.2 Market Segment Analysis

    • 1.3 Market Size 2022

    • 1.4 Anaplastic Astrocytoma Drug Market Outlook: Forecast for 2022 - 2028

    • 1.5 Pricing Analysis

    2 Executive Summary

    3 Anaplastic Astrocytoma Drug Market Lineage Outlook

    • 3.1 Parent Market Outlook

    • 3.2 Related/Ancillary Market Outlook

    • 3.3 Penetration & Growth Prospect Mapping, 2022

    4 Market Analysis Tools: Porter's Five Forces

    • 4.1 Supplier Power

    • 4.2 Buyer Power

    • 4.3 Substitution Threat

    • 4.4 Threat of New Entrants

    • 4.5 Competitive Rivalry

    5 Anaplastic Astrocytoma Drug Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)

    • 5.1 Political/Legal Landscape

    • 5.2 Economic Landscape

    • 5.3 Social Landscape

    • 5.4 Technology Landscape

    6 Anaplastic Astrocytoma Drug Market - Value Chain Analysis

    • 6.1 Industry's Value Chain Analysis

    • 6.2 Product Life Cycle

    • 6.3 User Perspective Analysis

    7 Region and Country-wise Anaplastic Astrocytoma Drug Market Analysis and Outlook to 2022

    • 7.1 Global Anaplastic Astrocytoma Drug Consumption (2017-2022)

    • 7.2 United States Anaplastic Astrocytoma Drug Consumption (2017-2022)

    • 7.3 Europe Anaplastic Astrocytoma Drug Consumption (2017-2022)

    • 7.4 China Anaplastic Astrocytoma Drug Consumption (2017-2022)

    • 7.5 Japan Anaplastic Astrocytoma Drug Consumption (2017-2022)

    • 7.6 India Anaplastic Astrocytoma Drug Consumption (2017-2022)

    • 7.7 South Korea Anaplastic Astrocytoma Drug Consumption (2017-2022)

    8 Region and Country-wise Anaplastic Astrocytoma Drug Market Analysis and Outlook to 2028

    • 8.1 Global Anaplastic Astrocytoma Drug Consumption Forecast (2022-2028)

    • 8.2 United States Anaplastic Astrocytoma Drug Consumption Forecast (2022-2028)

    • 8.3 Europe Anaplastic Astrocytoma Drug Consumption Forecast (2022-2028)

    • 8.4 China Anaplastic Astrocytoma Drug Consumption Forecast (2022-2028)

    • 8.5 Japan Anaplastic Astrocytoma Drug Consumption Forecast (2022-2028)

    • 8.6 India Anaplastic Astrocytoma Drug Consumption Forecast (2022-2028)

    • 8.7 South Korea Anaplastic Astrocytoma Drug Consumption Forecast (2022-2028)

    9 Global Anaplastic Astrocytoma Drug Market Outlook by Types and Applications to 2022

    • 9.1 Global Anaplastic Astrocytoma Drug Consumption and Growth Rate by Type (2017-2022)

      • 9.1.1 Global A-10 Consumption and Growth Rate (2017-2022)

      • 9.1.2 Global AS-21 Consumption and Growth Rate (2017-2022)

      • 9.1.3 Global AdRTSIL-12 Consumption and Growth Rate (2017-2022)

      • 9.1.4 Global ADU-623 Consumption and Growth Rate (2017-2022)

      • 9.1.5 Global Others Consumption and Growth Rate (2017-2022)

    • 9.2 Global Anaplastic Astrocytoma Drug Consumption and Growth Rate by Application (2017-2022)

      • 9.2.1 Global Hospital Consumption and Growth Rate (2017-2022)

      • 9.2.2 Global Clinic Consumption and Growth Rate (2017-2022)

      • 9.2.3 Global Others Consumption and Growth Rate (2017-2022)

    10 Global Anaplastic Astrocytoma Drug Market Outlook by Types and Applications to 2028

    • 10.1 Global Anaplastic Astrocytoma Drug Consumption Forecast and Growth Rate by Type (2022-2028)

      • 10.1.1 Global A-10 Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.2 Global AS-21 Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.3 Global AdRTSIL-12 Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.4 Global ADU-623 Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.5 Global Others Consumption Forecast and Growth Rate (2022-2028)

    • 10.2 Global Anaplastic Astrocytoma Drug Consumption Forecast and Growth Rate by Application (2022-2028)

      • 10.2.1 Global Hospital Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.2 Global Clinic Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.3 Global Others Consumption Forecast and Growth Rate (2022-2028)

    11 Global Anaplastic Astrocytoma Drug Import and Export Analysis (Top 5 Countries)

    • 11.1 Global Anaplastic Astrocytoma Drug Import by Region (Top 5 Countries) (2017-2028)

    • 11.2 Global Anaplastic Astrocytoma Drug Export by Region (Top 5 Countries) (2017-2028)

    12 Coronavirus Disease (COVID-19) Impact

    • 12.1 Industry Impact Analysis

    • 12.2 Anaplastic Astrocytoma Drug Market Outlook to 2028 - COVID-19 Affected Forecasts

    13 Competition Matrix

    • 13.1 Target Markets

    • 13.2 Comprehensive Analysis of Products in Competitive Markets

    14 Global Anaplastic Astrocytoma Drug Market Competitive Analysis

    • 14.1 TVAX Biomedical Inc

      • 14.1.1 TVAX Biomedical Inc Company Details

      • 14.1.2 TVAX Biomedical Inc Anaplastic Astrocytoma Drug Sales, Price, Value and Gross Profit (2017-2022)

      • 14.1.3 TVAX Biomedical Inc Anaplastic Astrocytoma Drug Product and Service

    • 14.2 Advantagene Inc

      • 14.2.1 Advantagene Inc Company Details

      • 14.2.2 Advantagene Inc Anaplastic Astrocytoma Drug Sales, Price, Value and Gross Profit (2017-2022)

      • 14.2.3 Advantagene Inc Anaplastic Astrocytoma Drug Product and Service

    • 14.3 Alfa Wassermann SpA

      • 14.3.1 Alfa Wassermann SpA Company Details

      • 14.3.2 Alfa Wassermann SpA Anaplastic Astrocytoma Drug Sales, Price, Value and Gross Profit (2017-2022)

      • 14.3.3 Alfa Wassermann SpA Anaplastic Astrocytoma Drug Product and Service

    • 14.4 ZIOPHARM Oncology Inc

      • 14.4.1 ZIOPHARM Oncology Inc Company Details

      • 14.4.2 ZIOPHARM Oncology Inc Anaplastic Astrocytoma Drug Sales, Price, Value and Gross Profit (2017-2022)

      • 14.4.3 ZIOPHARM Oncology Inc Anaplastic Astrocytoma Drug Product and Service

    • 14.5 Burzynski Research Institute Inc

      • 14.5.1 Burzynski Research Institute Inc Company Details

      • 14.5.2 Burzynski Research Institute Inc Anaplastic Astrocytoma Drug Sales, Price, Value and Gross Profit (2017-2022)

      • 14.5.3 Burzynski Research Institute Inc Anaplastic Astrocytoma Drug Product and Service

    • 14.6 Orbus Therapeutics Inc

      • 14.6.1 Orbus Therapeutics Inc Company Details

      • 14.6.2 Orbus Therapeutics Inc Anaplastic Astrocytoma Drug Sales, Price, Value and Gross Profit (2017-2022)

      • 14.6.3 Orbus Therapeutics Inc Anaplastic Astrocytoma Drug Product and Service

    • 14.7 AngioChem Inc

      • 14.7.1 AngioChem Inc Company Details

      • 14.7.2 AngioChem Inc Anaplastic Astrocytoma Drug Sales, Price, Value and Gross Profit (2017-2022)

      • 14.7.3 AngioChem Inc Anaplastic Astrocytoma Drug Product and Service

    • 14.8 Bayer AG

      • 14.8.1 Bayer AG Company Details

      • 14.8.2 Bayer AG Anaplastic Astrocytoma Drug Sales, Price, Value and Gross Profit (2017-2022)

      • 14.8.3 Bayer AG Anaplastic Astrocytoma Drug Product and Service

    • 14.9 Boehringer Ingelheim GmbH

      • 14.9.1 Boehringer Ingelheim GmbH Company Details

      • 14.9.2 Boehringer Ingelheim GmbH Anaplastic Astrocytoma Drug Sales, Price, Value and Gross Profit (2017-2022)

      • 14.9.3 Boehringer Ingelheim GmbH Anaplastic Astrocytoma Drug Product and Service

    • 14.10 Merrimack Pharmaceuticals Inc

      • 14.10.1 Merrimack Pharmaceuticals Inc Company Details

      • 14.10.2 Merrimack Pharmaceuticals Inc Anaplastic Astrocytoma Drug Sales, Price, Value and Gross Profit (2017-2022)

      • 14.10.3 Merrimack Pharmaceuticals Inc Anaplastic Astrocytoma Drug Product and Service

    • 14.11 Novartis AG

      • 14.11.1 Novartis AG Company Details

      • 14.11.2 Novartis AG Anaplastic Astrocytoma Drug Sales, Price, Value and Gross Profit (2017-2022)

      • 14.11.3 Novartis AG Anaplastic Astrocytoma Drug Product and Service

    • 14.12 Millennium Pharmaceuticals Inc

      • 14.12.1 Millennium Pharmaceuticals Inc Company Details

      • 14.12.2 Millennium Pharmaceuticals Inc Anaplastic Astrocytoma Drug Sales, Price, Value and Gross Profit (2017-2022)

      • 14.12.3 Millennium Pharmaceuticals Inc Anaplastic Astrocytoma Drug Product and Service

    • 14.13 Cavion LLC

      • 14.13.1 Cavion LLC Company Details

      • 14.13.2 Cavion LLC Anaplastic Astrocytoma Drug Sales, Price, Value and Gross Profit (2017-2022)

      • 14.13.3 Cavion LLC Anaplastic Astrocytoma Drug Product and Service

    • 14.14 Astellas Pharma Inc

      • 14.14.1 Astellas Pharma Inc Company Details

      • 14.14.2 Astellas Pharma Inc Anaplastic Astrocytoma Drug Sales, Price, Value and Gross Profit (2017-2022)

      • 14.14.3 Astellas Pharma Inc Anaplastic Astrocytoma Drug Product and Service

    • 14.15 Tragara Pharmaceuticals Inc

      • 14.15.1 Tragara Pharmaceuticals Inc Company Details

      • 14.15.2 Tragara Pharmaceuticals Inc Anaplastic Astrocytoma Drug Sales, Price, Value and Gross Profit (2017-2022)

      • 14.15.3 Tragara Pharmaceuticals Inc Anaplastic Astrocytoma Drug Product and Service

    • 14.16 Amgen Inc

      • 14.16.1 Amgen Inc Company Details

      • 14.16.2 Amgen Inc Anaplastic Astrocytoma Drug Sales, Price, Value and Gross Profit (2017-2022)

      • 14.16.3 Amgen Inc Anaplastic Astrocytoma Drug Product and Service

    • 14.17 Pfizer Inc

      • 14.17.1 Pfizer Inc Company Details

      • 14.17.2 Pfizer Inc Anaplastic Astrocytoma Drug Sales, Price, Value and Gross Profit (2017-2022)

      • 14.17.3 Pfizer Inc Anaplastic Astrocytoma Drug Product and Service

    • 14.18 Celldex Therapeutics Inc

      • 14.18.1 Celldex Therapeutics Inc Company Details

      • 14.18.2 Celldex Therapeutics Inc Anaplastic Astrocytoma Drug Sales, Price, Value and Gross Profit (2017-2022)

      • 14.18.3 Celldex Therapeutics Inc Anaplastic Astrocytoma Drug Product and Service

    • 14.19 Tocagen Inc

      • 14.19.1 Tocagen Inc Company Details

      • 14.19.2 Tocagen Inc Anaplastic Astrocytoma Drug Sales, Price, Value and Gross Profit (2017-2022)

      • 14.19.3 Tocagen Inc Anaplastic Astrocytoma Drug Product and Service

    15 Appendix


    TABLE OF CHARTS

    • Table Definition of Anaplastic Astrocytoma Drug

    • Figure Anaplastic Astrocytoma Drug Picture

    • Table Global Anaplastic Astrocytoma Drug Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Anaplastic Astrocytoma Drug Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Anaplastic Astrocytoma Drug Market: Year-over-year Growth 2022 - 2028 (%)

    • Table Parent Market Analysis

    • Figure Parent Market Price

    • Table Related/Ancillary Market Outlook Analysis

    • Table Supplier Power Analysis

    • Table Buyer Power Analysis

    • Table Substitution Threat Analysis

    • Table Threat of New Entrants Analysis

    • Table Competitive Rivalry Analysis

    • Figure Global Anaplastic Astrocytoma Drug Consumption by Country (2017-2022)

    • Figure United States Anaplastic Astrocytoma Drug Consumption and Growth Rate (2017-2022)

    • Table Europe Anaplastic Astrocytoma Drug Consumption and Growth Rate (2017-2022)

    • Figure China Anaplastic Astrocytoma Drug Consumption and Growth Rate (2017-2022)

    • Figure Japan Anaplastic Astrocytoma Drug Consumption and Growth Rate (2017-2022)

    • Figure India Anaplastic Astrocytoma Drug Consumption and Growth Rate (2017-2022)

    • Figure South Korea Anaplastic Astrocytoma Drug Consumption and Growth Rate (2017-2022)

    • Figure Global Anaplastic Astrocytoma Drug Consumption Forecast by Country (2022-2028)

    • Figure United States Anaplastic Astrocytoma Drug Consumption Forecast and Growth Rate (2022-2028)

    • Table Europe Anaplastic Astrocytoma Drug Consumption Forecast and Growth Rate (2022-2028)

    • Figure China Anaplastic Astrocytoma Drug Consumption Forecast and Growth Rate (2022-2028)

    • Figure Japan Anaplastic Astrocytoma Drug Consumption Forecast and Growth Rate (2022-2028)

    • Figure India Anaplastic Astrocytoma Drug Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Korea Anaplastic Astrocytoma Drug Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global A-10 Consumption and Growth Rate (2017-2022)

    • Figure Global AS-21 Consumption and Growth Rate (2017-2022)

    • Figure Global AdRTSIL-12 Consumption and Growth Rate (2017-2022)

    • Figure Global ADU-623 Consumption and Growth Rate (2017-2022)

    • Figure Global Others Consumption and Growth Rate (2017-2022)

    • Figure Global Hospital Consumption and Growth Rate (2017-2022)

    • Figure Global Clinic Consumption and Growth Rate (2017-2022)

    • Figure Global Others Consumption and Growth Rate (2017-2022)

    • Figure Global A-10 Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global AS-21 Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global AdRTSIL-12 Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global ADU-623 Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Others Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Hospital Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Clinic Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Others Consumption Forecast and Growth Rate (2022-2028)

    • Table Global Anaplastic Astrocytoma Drug Import by Region (Top 5 Countries) (2017-2028)

    • Table Global Anaplastic Astrocytoma Drug Export by Region (Top 5 Countries) (2017-2028)

    • Table TVAX Biomedical Inc (Foundation Year, Company Profile and etc.)

    • Table TVAX Biomedical Inc Anaplastic Astrocytoma Drug Sales, Price, Value and Gross Profit (2017-2022)

    • Table TVAX Biomedical Inc Anaplastic Astrocytoma Drug Product and Service

    • Table Advantagene Inc (Foundation Year, Company Profile and etc.)

    • Table Advantagene Inc Anaplastic Astrocytoma Drug Sales, Price, Value and Gross Profit (2017-2022)

    • Table Advantagene Inc Anaplastic Astrocytoma Drug Product and Service

    • Table Alfa Wassermann SpA (Foundation Year, Company Profile and etc.)

    • Table Alfa Wassermann SpA Anaplastic Astrocytoma Drug Sales, Price, Value and Gross Profit (2017-2022)

    • Table Alfa Wassermann SpA Anaplastic Astrocytoma Drug Product and Service

    • Table ZIOPHARM Oncology Inc (Foundation Year, Company Profile and etc.)

    • Table ZIOPHARM Oncology Inc Anaplastic Astrocytoma Drug Sales, Price, Value and Gross Profit (2017-2022)

    • Table ZIOPHARM Oncology Inc Anaplastic Astrocytoma Drug Product and Service

    • Table Burzynski Research Institute Inc (Foundation Year, Company Profile and etc.)

    • Table Burzynski Research Institute Inc Anaplastic Astrocytoma Drug Sales, Price, Value and Gross Profit (2017-2022)

    • Table Burzynski Research Institute Inc Anaplastic Astrocytoma Drug Product and Service

    • Table Orbus Therapeutics Inc (Foundation Year, Company Profile and etc.)

    • Table Orbus Therapeutics Inc Anaplastic Astrocytoma Drug Sales, Price, Value and Gross Profit (2017-2022)

    • Table Orbus Therapeutics Inc Anaplastic Astrocytoma Drug Product and Service

    • Table AngioChem Inc (Foundation Year, Company Profile and etc.)

    • Table AngioChem Inc Anaplastic Astrocytoma Drug Sales, Price, Value and Gross Profit (2017-2022)

    • Table AngioChem Inc Anaplastic Astrocytoma Drug Product and Service

    • Table Bayer AG (Foundation Year, Company Profile and etc.)

    • Table Bayer AG Anaplastic Astrocytoma Drug Sales, Price, Value and Gross Profit (2017-2022)

    • Table Bayer AG Anaplastic Astrocytoma Drug Product and Service

    • Table Boehringer Ingelheim GmbH (Foundation Year, Company Profile and etc.)

    • Table Boehringer Ingelheim GmbH Anaplastic Astrocytoma Drug Sales, Price, Value and Gross Profit (2017-2022)

    • Table Boehringer Ingelheim GmbH Anaplastic Astrocytoma Drug Product and Service

    • Table Merrimack Pharmaceuticals Inc (Foundation Year, Company Profile and etc.)

    • Table Merrimack Pharmaceuticals Inc Anaplastic Astrocytoma Drug Sales, Price, Value and Gross Profit (2017-2022)

    • Table Merrimack Pharmaceuticals Inc Anaplastic Astrocytoma Drug Product and Service

    • Table Novartis AG (Foundation Year, Company Profile and etc.)

    • Table Novartis AG Anaplastic Astrocytoma Drug Sales, Price, Value and Gross Profit (2017-2022)

    • Table Novartis AG Anaplastic Astrocytoma Drug Product and Service

    • Table Millennium Pharmaceuticals Inc (Foundation Year, Company Profile and etc.)

    • Table Millennium Pharmaceuticals Inc Anaplastic Astrocytoma Drug Sales, Price, Value and Gross Profit (2017-2022)

    • Table Millennium Pharmaceuticals Inc Anaplastic Astrocytoma Drug Product and Service

    • Table Cavion LLC (Foundation Year, Company Profile and etc.)

    • Table Cavion LLC Anaplastic Astrocytoma Drug Sales, Price, Value and Gross Profit (2017-2022)

    • Table Cavion LLC Anaplastic Astrocytoma Drug Product and Service

    • Table Astellas Pharma Inc (Foundation Year, Company Profile and etc.)

    • Table Astellas Pharma Inc Anaplastic Astrocytoma Drug Sales, Price, Value and Gross Profit (2017-2022)

    • Table Astellas Pharma Inc Anaplastic Astrocytoma Drug Product and Service

    • Table Tragara Pharmaceuticals Inc (Foundation Year, Company Profile and etc.)

    • Table Tragara Pharmaceuticals Inc Anaplastic Astrocytoma Drug Sales, Price, Value and Gross Profit (2017-2022)

    • Table Tragara Pharmaceuticals Inc Anaplastic Astrocytoma Drug Product and Service

    • Table Amgen Inc (Foundation Year, Company Profile and etc.)

    • Table Amgen Inc Anaplastic Astrocytoma Drug Sales, Price, Value and Gross Profit (2017-2022)

    • Table Amgen Inc Anaplastic Astrocytoma Drug Product and Service

    • Table Pfizer Inc (Foundation Year, Company Profile and etc.)

    • Table Pfizer Inc Anaplastic Astrocytoma Drug Sales, Price, Value and Gross Profit (2017-2022)

    • Table Pfizer Inc Anaplastic Astrocytoma Drug Product and Service

    • Table Celldex Therapeutics Inc (Foundation Year, Company Profile and etc.)

    • Table Celldex Therapeutics Inc Anaplastic Astrocytoma Drug Sales, Price, Value and Gross Profit (2017-2022)

    • Table Celldex Therapeutics Inc Anaplastic Astrocytoma Drug Product and Service

    • Table Tocagen Inc (Foundation Year, Company Profile and etc.)

    • Table Tocagen Inc Anaplastic Astrocytoma Drug Sales, Price, Value and Gross Profit (2017-2022)

    • Table Tocagen Inc Anaplastic Astrocytoma Drug Product and Service


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US